Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD)
Open Access
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-13
- https://doi.org/10.1038/s41598-020-80647-w
Abstract
Brain tumors are the most common solid tumors in childhood. There is the need for biomarkers of residual disease, therapy response and recurrence. Cerebrospinal fluid (CSF) is a source of brain tumor biomarkers. We analyzed the proteome of waste CSF from extraventricular drainage (EVD) from 29 children bearing different brain tumors and 17 controls needing EVD insertion for unrelated causes. 1598 and 1526 proteins were identified by liquid chromatography-coupled tandem mass spectrometry proteomics in CSF control and brain tumor patients, respectively, 263 and 191 proteins being exclusive of either condition. Bioinformatic analysis revealed promising protein biomarkers for the discrimination between control and tumor (TATA-binding protein-associated factor 15 and S100 protein B). Moreover, Thymosin beta-4 (TMSB4X) and CD109, and 14.3.3 and HSP90 alpha could discriminate among other brain tumors and low-grade gliomas plus glyoneuronal tumors/pilocytic astrocytoma, or embryonal tumors/medulloblastoma. Biomarkers were validated by ELISA assay. Our method was able to distinguish among brain tumor vs non-tumor/hemorrhagic conditions (controls) and to differentiate two large classes of brain tumors. Further prospective studies may assess whether the biomarkers proposed by our discovery approach can be identified in other bodily fluids, therefore less invasively, and are useful to guide therapy and predict recurrences.Funding Information
- Renal Child Foundation
- Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini
This publication has 72 references indexed in Scilit:
- Biomarkers of Pediatric Brain TumorsFrontiers in Pediatrics, 2013
- Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma ModelPLOS ONE, 2012
- Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical PracticePLOS ONE, 2012
- Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MSPLOS ONE, 2012
- 14-3-3 zeta as novel molecular target for cancer therapyEmerging Therapeutic Targets, 2012
- Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluidNeuro-Oncology, 2012
- Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium studyProteomics, 2011
- Establishing the Proteome of Normal Human Cerebrospinal FluidPLOS ONE, 2010
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature, 2008
- Multiplicity of cerebrospinal fluid functions: New challenges in health and diseaseFluids and Barriers of the CNS, 2008